Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T01:25:00.605Z Has data issue: false hasContentIssue false
  • English
  • Français

Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction

Published online by Cambridge University Press:  12 October 2020

David K. Warren Open the ORCID record for David K. Warren [Opens in a new window] ,
Katelin B. Nickel Open the ORCID record for Katelin B. Nickel [Opens in a new window] ,
Christopher J. Hostler Open the ORCID record for Christopher J. Hostler [Opens in a new window] ,
Katherine Foy ,
Jennifer H. Han ,
Pam Tolomeo Open the ORCID record for Pam Tolomeo [Opens in a new window] ,
Ian R. Banks ,
Victoria J. Fraser Open the ORCID record for Victoria J. Fraser [Opens in a new window] ,
Margaret A. Olsen Open the ORCID record for Margaret A. Olsen [Opens in a new window]  and
for the CDC Prevention Epicenter Program
David K. Warren
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
Katelin B. Nickel
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
Christopher J. Hostler
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University School of Medicine, Durham, North Carolina Infectious Diseases Section, Durham VA Health Care System, Durham, North Carolina
Katherine Foy
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University School of Medicine, Durham, North Carolina
Jennifer H. Han
Affiliation:
Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Present affiliation: GlaxoSmithKline, Rockville, Maryland
Pam Tolomeo
Affiliation:
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Ian R. Banks
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
Victoria J. Fraser
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
Margaret A. Olsen*
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri
*
Author for correspondence: Margaret A. Olsen, E-mail: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Multiple guidelines recommend discontinuation of prophylactic antibiotics <24 hours after surgery. In a multicenter, retrospective cohort of 2,954 mastectomy patients ± immediate breast reconstruction, we found that utilization of prophylactic postdischarge antibiotics varied dramatically at the surgeon level among general surgeons and was virtually universal among plastic surgeons.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 42 , Issue 4 , April 2021 , pp. 467 - 470
Check for updates
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Berrios-Torres, SI, Umscheid, CA, Bratzler, DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017;152:784–791.Google ScholarPubMed
Alderman, A, Gutowski, K, Ahuja, A, Gray, D. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg 2014;134:648e–655e.CrossRefGoogle ScholarPubMed
Phillips, BT, Wang, ED, Mirrer, J, et al. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg 2011;66:460–465.CrossRefGoogle ScholarPubMed
Brahmbhatt, RD, Huebner, M, Scow, JS, et al. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol 2012;19:3205–3211.Google ScholarPubMed
Elixhauser, A, Steiner, C, Harris, R, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.CrossRefGoogle ScholarPubMed
National Healthcare Safety Network procedure-associated module: surgical site infection event. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf. Published 2015. Accessed June 17, 2015.Google Scholar
Hai, Y, Chong, W, Lazar, MA. Extended prophylactic antibiotics for mastectomy with immediate breast reconstruction: a meta-analysis. Plastic Reconstruct Surg Global Open 2020;8:e2613.CrossRefGoogle ScholarPubMed
Harbarth, S, Samore, MH, Lichtenberg, D, Carmeli, Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101:2916–2921.CrossRefGoogle ScholarPubMed
Branch-Elliman, W, O’Brien, W, Strymish, J, Itani, K, Wyatt, C, Gupta, K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg 2019;154:590–598.CrossRefGoogle ScholarPubMed
Sartelli, M, Duane, TM, Catena, F, et al. Antimicrobial stewardship: a call to action for surgeons. Surg Infect (Larchmt) 2016;17:625–631.CrossRefGoogle Scholar
Supplementary material: File

Warren et al. supplementary material

Appendix

Download Warren et al. supplementary material(File)
File 22.4 KB